• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有苯丙酮尿症的儿童和青少年的代谢控制和身体成分。

METABOLIC CONTROL AND BODY COMPOSITION OF CHILDREN AND ADOLESCENTS WITH PHENYLKETONURIA.

机构信息

Universidade Federal da Bahia, Salvador, BA, Brazil.

Universidade do Estado da Bahia, Salvador, BA, Brazil.

出版信息

Rev Paul Pediatr. 2021 Feb 24;39:e2020095. doi: 10.1590/1984-0462/2021/39/2020095. eCollection 2021.

DOI:10.1590/1984-0462/2021/39/2020095
PMID:33656145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7903412/
Abstract

OBJECTIVE

To characterize metabolic control and verify whether it has any relation with socioeconomic, demographic, and body composition variables in children and adolescents with phenylketonuria (PKU) diagnosed in the neonatal period.

METHODS

This cohort study collected retrospective data of 53 phenylketonuric children and adolescents. Data on family income, housing, and mother's age and schooling level were collected, and anthropometric measures of body composition and distribution were taken. All dosages of phenylalanine (Phe) from the last five years (2015-2019) were evaluated and classified regarding their adequacy (cutoffs: 0-12 years: 2-6 mg/dL; 12-19 years: 2-10 mg/dL). Adequate metabolic control was considered if ≥7%) of the dosages were within desired ranges.

RESULTS

The mean (±standard deviation) age in the last year was 10.1±4.6 years. Most of them were under 12 years old (33/53; 62.3%) and had the classic form of the disease (39/53; 73.6%). Better metabolic control was observed among adolescents (68.4 versus 51.4%; p=0.019). Overweight was found in 9/53 (17%) and higher serum Phe levels (p<0.001) were found in this group of patients. Metabolic control with 70% or more Phe level adequacy decreased along with the arm muscle area (AMA) (ptendency=0.042), being 70.0% among those with low reserve (low AMA), and 18.5% among those with excessive reserve (high AMA).

CONCLUSIONS

Adequate metabolic control was observed in most patients. The findings suggest that, in this sample, the levels of phenylalanine may be related to changes in body composition.

摘要

目的

描述新生儿期诊断为苯丙酮尿症(PKU)的儿童和青少年的代谢控制情况,并验证其与社会经济、人口统计学和身体成分变量之间的关系。

方法

本队列研究收集了 53 名苯丙酮尿症儿童和青少年的回顾性数据。收集了家庭收入、住房以及母亲年龄和受教育程度的数据,并进行了身体成分和分布的人体测量学测量。评估了过去五年(2015-2019 年)的所有苯丙氨酸(Phe)剂量,并根据其充足性进行分类(切点:0-12 岁:2-6mg/dL;12-19 岁:2-10mg/dL)。如果≥7%的剂量在理想范围内,则认为代谢控制充足。

结果

最后一年的平均(±标准差)年龄为 10.1±4.6 岁。他们大多数(33/53;62.3%)年龄在 12 岁以下,且患有经典型疾病(39/53;73.6%)。青少年的代谢控制更好(68.4%比 51.4%;p=0.019)。53 例患者中有 9 例(17%)超重,且该组患者的血清 Phe 水平较高(p<0.001)。随着臂肌区(AMA)的减少,70%或更多的 Phe 水平充足率降低(趋势=0.042),低储备(低 AMA)者为 70.0%,高储备(高 AMA)者为 18.5%。

结论

大多数患者的代谢控制充足。研究结果表明,在该样本中,苯丙氨酸水平可能与身体成分的变化有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff8d/7903412/48c36293879e/1984-0462-rpp-39-e2020095-gch1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff8d/7903412/48c36293879e/1984-0462-rpp-39-e2020095-gch1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff8d/7903412/48c36293879e/1984-0462-rpp-39-e2020095-gch1.jpg

相似文献

1
METABOLIC CONTROL AND BODY COMPOSITION OF CHILDREN AND ADOLESCENTS WITH PHENYLKETONURIA.患有苯丙酮尿症的儿童和青少年的代谢控制和身体成分。
Rev Paul Pediatr. 2021 Feb 24;39:e2020095. doi: 10.1590/1984-0462/2021/39/2020095. eCollection 2021.
2
The relationship between dietary intake, growth and body composition in Phenylketonuria.苯丙酮尿症患者的饮食摄入、生长和身体成分之间的关系。
Mol Genet Metab. 2017 Sep;122(1-2):36-42. doi: 10.1016/j.ymgme.2017.07.007. Epub 2017 Jul 20.
3
Neonatal phenylalanine wash-out in phenylketonuria.新生儿苯丙酮尿症的苯丙氨酸洗脱。
Metab Brain Dis. 2020 Oct;35(7):1225-1229. doi: 10.1007/s11011-020-00602-6. Epub 2020 Jul 13.
4
Early dietary treated patients with phenylketonuria can achieve normal growth and body composition.早期饮食治疗的苯丙酮尿症患者可以实现正常的生长和身体成分。
Mol Genet Metab. 2013;110 Suppl:S40-3. doi: 10.1016/j.ymgme.2013.10.009. Epub 2013 Oct 22.
5
Therapy compliance in children with phenylketonuria younger than 5 years: A cohort study.5 岁以下苯丙酮尿症患儿治疗依从性:一项队列研究。
Adv Clin Exp Med. 2019 Oct;28(10):1385-1391. doi: 10.17219/acem/104536.
6
Growth and Nutritional Status of Phenylketonuric Children and Adolescents.苯丙酮尿症患儿和青少年的生长和营养状况。
BMC Pediatr. 2022 Nov 17;22(1):664. doi: 10.1186/s12887-022-03715-2.
7
Altered tetrahydrobiopterin metabolism in patients with phenylalanine hydroxylase deficiency.苯丙氨酸羟化酶缺乏症患者四氢生物蝶呤代谢的改变。
Eur J Pediatr. 2017 Jul;176(7):917-924. doi: 10.1007/s00431-017-2932-x. Epub 2017 May 24.
8
5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.5 年回顾性分析在两家专业诊所治疗的苯丙酮尿症(PKU)和高苯丙氨酸血症患者。
Mol Genet Metab. 2020 Mar;129(3):177-185. doi: 10.1016/j.ymgme.2019.12.007. Epub 2019 Dec 10.
9
Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations.葡萄牙代谢中心对苯丙酮尿症患者的代谢控制:三种不同建议的比较。
Nutrients. 2021 Sep 6;13(9):3118. doi: 10.3390/nu13093118.
10
Nutritional and metabolic parameters of children and adolescents with phenylketonuria.儿童和青少年苯丙酮尿症的营养和代谢参数。
Clin Nutr ESPEN. 2020 Jun;37:44-49. doi: 10.1016/j.clnesp.2020.03.024. Epub 2020 Apr 15.

引用本文的文献

1
Current state of the treatment landscape of phenylketonuria.苯丙酮尿症治疗现状
Orphanet J Rare Dis. 2025 Jun 5;20(1):281. doi: 10.1186/s13023-025-03840-y.
2
Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria.苯丙酮尿症患者的身体成分评估和心血管代谢风险的临床标志物。
Nutrients. 2023 Dec 18;15(24):5133. doi: 10.3390/nu15245133.

本文引用的文献

1
Body fat percentage in adolescents with phenylketonuria and associated factors.苯丙酮尿症青少年的体脂百分比及相关因素
Mol Genet Metab Rep. 2020 May 12;23:100595. doi: 10.1016/j.ymgmr.2020.100595. eCollection 2020 Jun.
2
Nutritional and metabolic parameters of children and adolescents with phenylketonuria.儿童和青少年苯丙酮尿症的营养和代谢参数。
Clin Nutr ESPEN. 2020 Jun;37:44-49. doi: 10.1016/j.clnesp.2020.03.024. Epub 2020 Apr 15.
3
Nutritional and Metabolic Characteristics of UK Adult Phenylketonuria Patients with Varying Dietary Adherence.
英国成年苯丙酮尿症患者不同饮食依从性的营养和代谢特征。
Nutrients. 2019 Oct 14;11(10):2459. doi: 10.3390/nu11102459.
4
Change in overweight and obesity over a decade according to sociodemographic factors in Brazilian adolescents.根据巴西青少年的社会人口学因素,超重和肥胖情况在十年间的变化。
Cien Saude Colet. 2019 Sep 9;24(9):3335-3344. doi: 10.1590/1413-81232018249.29052017.
5
Nutritional status of Brazilian schoolchildren: National Adolescent School-based Health Survey 2015.巴西学童的营养状况:2015年全国青少年学校健康调查
Rev Bras Epidemiol. 2018 Nov 29;21(suppl 1):e180008. doi: 10.1590/1980-549720180008.supl.1.
6
[Health and socio-educational needs of the families and children with rare metabolic diseases: Qualitative study in a tertiary hospital].[罕见代谢疾病家庭及儿童的健康与社会教育需求:三级医院的定性研究]
An Pediatr (Engl Ed). 2019 Jan;90(1):42-50. doi: 10.1016/j.anpedi.2018.03.003. Epub 2018 May 28.
7
The complete European guidelines on phenylketonuria: diagnosis and treatment.《苯丙酮尿症的完整欧洲指南:诊断与治疗》。
Orphanet J Rare Dis. 2017 Oct 12;12(1):162. doi: 10.1186/s13023-017-0685-2.
8
The relationship between dietary intake, growth and body composition in Phenylketonuria.苯丙酮尿症患者的饮食摄入、生长和身体成分之间的关系。
Mol Genet Metab. 2017 Sep;122(1-2):36-42. doi: 10.1016/j.ymgme.2017.07.007. Epub 2017 Jul 20.
9
Treatment adherence during childhood in individuals with phenylketonuria: Early signs of treatment discontinuation.苯丙酮尿症患者儿童期的治疗依从性:治疗中断的早期迹象。
Mol Genet Metab Rep. 2017 Apr 28;11:54-58. doi: 10.1016/j.ymgmr.2017.04.006. eCollection 2017 Jun.
10
Dietary glycemic index, glycemic load and metabolic profile in children with phenylketonuria.苯丙酮尿症患儿的膳食血糖生成指数、血糖负荷与代谢谱
Nutr Metab Cardiovasc Dis. 2017 Feb;27(2):176-182. doi: 10.1016/j.numecd.2016.11.002. Epub 2016 Nov 21.